1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-X0006C |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Transfected Stable Cell Lines |
Size/Quantity | 1 vial |
Cell Type | Lymphocyte |
Shipping Info | Dry Ice |
Growth Conditions | 37 °C, 5% CO₂ |
Source Organ | Lymphatic |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Overexpression Stable Cell Lines |
Host Cell | BAF3 |
Human FGFR3 (TACC3_Y373C) BAF3 Cell Line is a genetically engineered model derived from selected murine Ba/F3 parental cell line based on customers’ requirement. FGFR3 (TACC3_Y373C) BAF3 mutant cell line is generated by stable integration of exogenous human FGFR3 gene harboring the TACC3_Y373C composite mutation/fusion into Ba/F3 host cells using our optimized transduction of lentiviral vectors.
Target
The FGFR3-TACC3 fusion involves the fibroblast growth factor receptor 3 (FGFR3) and transforming acidic coiled-coil containing protein 3 (TACC3), often coupled with point mutations such as Y373C that enhance oncogenicity. The fusion promotes constitutive FGFR3 kinase activity, disrupted mitotic spindle regulation, and activation of MAPK/ERK and PI3K/AKT pathways. This composite alteration has been observed in glioblastoma, bladder cancer, and lung cancer, and represents a potential therapeutic target. AcceGen offers generation of stable overexpression or fusion gene cell lines targeting any gene or variant of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
For research use only